AMGN vs. ATR: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at AMGN and ATR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | AMGN | ATR |
|---|---|---|
| Company Name | Amgen Inc. | AptarGroup, Inc. |
| Country | United States | United States |
| GICS Sector | Health Care | Materials |
| GICS Industry | Biotechnology | Containers & Packaging |
| Market Capitalization | 158.61 billion USD | 8.67 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | June 17, 1983 | April 23, 1993 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of AMGN and ATR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | AMGN | ATR |
|---|---|---|
| 5-Day Price Return | -0.93% | -1.18% |
| 13-Week Price Return | -0.64% | -17.60% |
| 26-Week Price Return | -4.92% | -11.48% |
| 52-Week Price Return | -7.19% | -17.06% |
| Month-to-Date Return | 4.40% | -1.53% |
| Year-to-Date Return | 13.04% | -16.23% |
| 10-Day Avg. Volume | 2.57M | 0.39M |
| 3-Month Avg. Volume | 2.37M | 0.43M |
| 3-Month Volatility | 25.90% | 24.82% |
| Beta | 0.46 | 0.53 |
Profitability
Return on Equity (TTM)
AMGN
97.92%
Biotechnology Industry
- Max
- 97.92%
- Q3
- 11.99%
- Median
- -19.30%
- Q1
- -51.29%
- Min
- -132.03%
In the upper quartile for the Biotechnology industry, AMGN’s Return on Equity of 97.92% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
ATR
15.30%
Containers & Packaging Industry
- Max
- 36.99%
- Q3
- 19.86%
- Median
- 10.47%
- Q1
- 6.76%
- Min
- -0.20%
ATR’s Return on Equity of 15.30% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
AMGN
18.96%
Biotechnology Industry
- Max
- 73.34%
- Q3
- 18.98%
- Median
- -12.96%
- Q1
- -105.72%
- Min
- -259.82%
AMGN’s Net Profit Margin of 18.96% is aligned with the median group of its peers in the Biotechnology industry. This indicates its ability to convert revenue into profit is typical for the sector.
ATR
10.86%
Containers & Packaging Industry
- Max
- 10.84%
- Q3
- 8.25%
- Median
- 4.91%
- Q1
- 3.65%
- Min
- -0.12%
ATR’s Net Profit Margin of 10.86% is exceptionally high, placing it well beyond the typical range for the Containers & Packaging industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
Operating Profit Margin (TTM)
AMGN
24.01%
Biotechnology Industry
- Max
- 78.85%
- Q3
- 21.90%
- Median
- -13.30%
- Q1
- -109.94%
- Min
- -278.10%
An Operating Profit Margin of 24.01% places AMGN in the upper quartile for the Biotechnology industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
ATR
14.26%
Containers & Packaging Industry
- Max
- 22.03%
- Q3
- 13.09%
- Median
- 8.06%
- Q1
- 6.46%
- Min
- -0.07%
An Operating Profit Margin of 14.26% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | AMGN | ATR |
|---|---|---|
| Return on Equity (TTM) | 97.92% | 15.30% |
| Return on Assets (TTM) | 7.35% | 8.50% |
| Net Profit Margin (TTM) | 18.96% | 10.86% |
| Operating Profit Margin (TTM) | 24.01% | 14.26% |
| Gross Profit Margin (TTM) | 69.71% | 38.32% |
Financial Strength
Current Ratio (MRQ)
AMGN
1.31
Biotechnology Industry
- Max
- 16.97
- Q3
- 8.39
- Median
- 4.11
- Q1
- 2.64
- Min
- 0.74
AMGN’s Current Ratio of 1.31 falls into the lower quartile for the Biotechnology industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
ATR
1.21
Containers & Packaging Industry
- Max
- 1.96
- Q3
- 1.45
- Median
- 1.33
- Q1
- 1.09
- Min
- 0.87
ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
AMGN
7.57
Biotechnology Industry
- Max
- 1.92
- Q3
- 0.79
- Median
- 0.12
- Q1
- 0.00
- Min
- 0.00
With a Debt-to-Equity Ratio of 7.57, AMGN operates with exceptionally high leverage compared to the Biotechnology industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
ATR
0.40
Containers & Packaging Industry
- Max
- 4.15
- Q3
- 2.03
- Median
- 1.20
- Q1
- 0.53
- Min
- 0.23
Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio (TTM)
AMGN
2.40
Biotechnology Industry
- Max
- 72.37
- Q3
- 1.03
- Median
- -9.59
- Q1
- -65.05
- Min
- -163.11
AMGN’s Interest Coverage Ratio of 2.40 is in the upper quartile for the Biotechnology industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
ATR
16.67
Containers & Packaging Industry
- Max
- 13.16
- Q3
- 8.10
- Median
- 3.38
- Q1
- 2.83
- Min
- 1.06
With an Interest Coverage Ratio of 16.67, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.
Financial Strength at a Glance
| Symbol | AMGN | ATR |
|---|---|---|
| Current Ratio (MRQ) | 1.31 | 1.21 |
| Quick Ratio (MRQ) | 0.98 | 0.83 |
| Debt-to-Equity Ratio (MRQ) | 7.57 | 0.40 |
| Interest Coverage Ratio (TTM) | 2.40 | 16.67 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
AMGN
3.08%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
AMGN’s Dividend Yield of 3.08% is exceptionally high, placing it well above the typical range for the Biotechnology industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.
ATR
1.38%
Containers & Packaging Industry
- Max
- 7.14%
- Q3
- 4.65%
- Median
- 3.69%
- Q1
- 2.00%
- Min
- 0.00%
ATR’s Dividend Yield of 1.38% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.
Dividend Payout Ratio (TTM)
AMGN
82.64%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
At 82.64%, AMGN’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Biotechnology industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.
ATR
30.61%
Containers & Packaging Industry
- Max
- 222.75%
- Q3
- 132.16%
- Median
- 65.79%
- Q1
- 28.53%
- Min
- 0.00%
ATR’s Dividend Payout Ratio of 30.61% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | AMGN | ATR |
|---|---|---|
| Dividend Yield (TTM) | 3.08% | 1.38% |
| Dividend Payout Ratio (TTM) | 82.64% | 30.61% |
Valuation
Price-to-Earnings Ratio (TTM)
AMGN
24.03
Biotechnology Industry
- Max
- 40.44
- Q3
- 39.37
- Median
- 22.12
- Q1
- 15.76
- Min
- 3.48
AMGN’s P/E Ratio of 24.03 is within the middle range for the Biotechnology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
ATR
22.12
Containers & Packaging Industry
- Max
- 24.22
- Q3
- 20.28
- Median
- 17.07
- Q1
- 15.06
- Min
- 7.79
A P/E Ratio of 22.12 places ATR in the upper quartile for the Containers & Packaging industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.
Price-to-Sales Ratio (TTM)
AMGN
4.55
Biotechnology Industry
- Max
- 92.67
- Q3
- 41.36
- Median
- 8.45
- Q1
- 4.46
- Min
- 0.97
AMGN’s P/S Ratio of 4.55 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
ATR
2.40
Containers & Packaging Industry
- Max
- 1.99
- Q3
- 1.17
- Median
- 0.94
- Q1
- 0.55
- Min
- 0.31
With a P/S Ratio of 2.40, ATR trades at a valuation that eclipses even the highest in the Containers & Packaging industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
Price-to-Book Ratio (MRQ)
AMGN
20.21
Biotechnology Industry
- Max
- 22.72
- Q3
- 10.68
- Median
- 4.55
- Q1
- 2.44
- Min
- 0.59
AMGN’s P/B Ratio of 20.21 is in the upper tier for the Biotechnology industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
ATR
3.83
Containers & Packaging Industry
- Max
- 4.79
- Q3
- 3.32
- Median
- 2.14
- Q1
- 1.60
- Min
- 0.89
ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | AMGN | ATR |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 24.03 | 22.12 |
| Price-to-Sales Ratio (TTM) | 4.55 | 2.40 |
| Price-to-Book Ratio (MRQ) | 20.21 | 3.83 |
| Price-to-Free Cash Flow Ratio (TTM) | 14.49 | 25.35 |